TG THERAPEUTICS INC. - COMMON STOCK
16.35
20-May-24 09:38:15
15 minutes delayed
Stocks
-0.13
-0.79%
Today's range
16.23 - 16.65
ISIN
N/A
Source
NASDAQ
-
TG Therapeutics Announces Scheduling of Planned Oncologic Drug Advisory Committee Meeting
10 Mar 2022 07:15:30 By Nasdaq GlobeNewswire
-
03 Mar 2022 07:00:01 By Nasdaq GlobeNewswire
-
01 Mar 2022 06:30:00 By Nasdaq GlobeNewswire
-
24 Feb 2022 06:30:01 By Nasdaq GlobeNewswire
-
TG Therapeutics to Participate in the B. Riley Securities 2022 Virtual Oncology Investor Conference
24 Jan 2022 06:30:00 By Nasdaq GlobeNewswire
-
TG Therapeutics to Participate in the 40th Annual J.P. Morgan Healthcare Conference
05 Jan 2022 06:30:00 By Nasdaq GlobeNewswire
-
TG Therapeutics Expands Term Loan Facility With Hercules Capital to $200 Million
04 Jan 2022 06:30:00 By Nasdaq GlobeNewswire
-
14 Dec 2021 06:30:00 By Nasdaq GlobeNewswire
-
14 Dec 2021 06:15:00 By Nasdaq GlobeNewswire
-
13 Dec 2021 06:30:00 By Nasdaq GlobeNewswire
-
10 Dec 2021 06:30:00 By Nasdaq GlobeNewswire
-
TG Therapeutics Provides Regulatory Update
30 Nov 2021 06:30:00 By Nasdaq GlobeNewswire
-
TG Therapeutics to Participate in the Jefferies London Healthcare Conference
15 Nov 2021 06:30:01 By Nasdaq GlobeNewswire
-
04 Nov 2021 08:34:14 By Nasdaq GlobeNewswire
-
TG Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results
04 Nov 2021 06:00:02 By Nasdaq GlobeNewswire
-
TG Therapeutics to Host Conference Call on Third Quarter 2021 Financial Results and Business Update
01 Nov 2021 06:30:00 By Nasdaq GlobeNewswire
-
14 Oct 2021 09:45:00 By Nasdaq GlobeNewswire